Moreover, CD133 may represent a putative cancer stem cell marker in many solid tumors, such as human colon cancer [8,9], prostate tumor [10,11], pancreatic adenocarcinoma [12], renal cancer [13], neural tumor [14-17], and hepatocellular carcinoma [18,19]. The gene discussed is PROM1; the disease is hepatocellular carcinoma.